One-year outcome of a prospective trial stopping dual antiplatelet therapy at 3 months after everolimus-eluting cobalt-chromium stent implantation: ShortT and OPtimal duration of Dual AntiPlatelet Therapy after everolimus-eluting cobalt-chromium stent (STOPDAPT) trialMasahiro Natsuaki, Takeshi Kimura, Takeshi Morimoto et al.|Cardiovascular Intervention and Therapeutics|2015Cited by 77
Nivolumab Induces Sustained Liver Injury in a Patient with Malignant MelanomaTokuhiro Matsubara, Masami Inada, Tsutomu Nishida et al.|Internal Medicine|2018Cited by 35
The combination of anti‑HBc and anti‑HBs levels is a useful predictor of the development of chemotherapy‑induced reactivation in lymphoma patients with resolved HBV infectionTokuhiro Matsubara, Masami Inada, Tsutomu Nishida et al.|Oncology Letters|2017Cited by 32
Number of polyps detected is a useful indicator of quality of clinical colonoscopyTakahiro Amano, Masami Inada, Tsutomu Nishida et al.|Endoscopy International Open|2018Cited by 23
Frequency of coexistent carcinoma in sessile serrated adenoma/polyps and traditional serrated adenomas removed by endoscopic resectionHirotsugu Saiki, Shiro Adachi, Tsutomu Nishida et al.|Endoscopy International Open|2016Cited by 19